home / stock / hypr / hypr news


HYPR News and Press, Hyperfine Inc. From 10/06/22

Stock Information

Company Name: Hyperfine Inc.
Stock Symbol: HYPR
Market: NASDAQ
Website: hyperfine.io

Menu

HYPR HYPR Quote HYPR Short HYPR News HYPR Articles HYPR Message Board
Get HYPR Alerts

News, Short Squeeze, Breakout and More Instantly...

HYPR - Hyperfine appoints Maria Sainz as President, CEO

Hyperfine ( NASDAQ: HYPR ) has named medical device industry veteran Maria Sainz as President and CEO of Hyperfine, effective Oct. 24, 2022. Scott Huennekens, who currently serves as interim President and CEO, will stay on as Executive Chairperson of the Board. HYPR ...

HYPR - Hyperfine Names Maria Sainz President and Chief Executive Officer

GUILFORD, Conn., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), (“Hyperfine” or “the Company”), the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced that ...

HYPR - BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council

SAN JOSE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the appointment of Tamara Elias, M.D., Senior Vice President at Nuance, and Scott Huennek...

HYPR - Hyperfine to Participate in Upcoming Investor Conferences

GUILFORD, Conn., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Hyperfine (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today announced that management will present at two upcoming conferences: Scott Huennekens, Interim President and Chief...

HYPR - Hyperfine downgraded to equal weight at Wells Fargo following Q2 results, reduced guidance

Wells Fargo has downgraded Hyperfine ( NASDAQ: HYPR ) to equal weight from overweight following disappointing Q2 2022 results Wednesday that included lowering guidance . The firm also cut its price target to $2.40 from $8 (~29% upside based on Wednesday's close). T...

HYPR - T2 Biosystems, Veru top healthcare gainers; Athenex, Invitae lead losers' pack

Gainers: T2 Biosystems ( TTOO ) +73% . Veru ( VERU ) +38% . Ginkgo Bioworks ( DNA ) +21% . Inotiv ( NOTV ) +20% . Accuray ( ARAY ) +17% . Losers: Athenex ( ATNX ) -46% . Invitae ( NVTA ) -43% . Cer...

HYPR - Sanofi, GSK, AppLovin among premarket losers' pack

Athenex ( ATNX ) -41% on pricing $30M in stock and warrants offering . Invitae ( NVTA ) -25% . Hyperfine ( HYPR ) -17% on Q2 earnings release . Sonos ( SONO ) -17% on Q3 earnings release . Six Flags Entertainment ( SIX ) ...

HYPR - Hyperfine, Inc. (HYPR) CEO Scott Huennekens on Q2 2022 Results - Earnings Call Transcript

Hyperfine, Inc. (HYPR) Q2 2022 Earnings Conference Call August 10, 2022, 16:30 PM ET Company Participants Marissa Bych - Gilmartin Group LLC Scott Huennekens - Interim President and Chief Executive Officer Alok Gupta - Chief Financial Officer Conference Cal...

HYPR - Hyperfine GAAP EPS of -$0.33 misses by $0.06, revenue of $1.53M misses by $0.47M

Hyperfine press release ( NASDAQ: HYPR ): Q2 GAAP EPS of -$0.33 misses by $0.06 . Revenue of $1.53M (+337.1% Y/Y) misses by $0.47M . For further details see: Hyperfine GAAP EPS of -$0.33 misses by $0.06, revenue of $1.53M misses by $0.47M

HYPR - Hyperfine Reports Second Quarter 2022 Financial Results

GUILFORD, Conn., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today reported financial results for the quarter ended June 30, 2022. Management will host a corresponding conference cal...

Previous 10 Next 10